Adeps suillus, Adrenalinium, Adrenocorticotrophin, Agrimonia eupatoria flos, Ammounium bromatum, Anacardium orientale, Antimonium crudum, Castanea sativa flos, Calcarea carbonica, Coenzyme A, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Pituitarum posterium, RNA, Sabadilla, Staphysagria, Thyroidinum

FDA Drug Profile — Thinnr PROTOCOL

Adeps suillus, Adrenalinium, Adrenocorticotrophin, Agrimonia eupatoria flos, Ammounium bromatum, Anacardium orientale, Antimonium crudum, Castanea sativa flos, Calcarea carbonica, Coenzyme A, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Pituitarum posterium, RNA, Sabadilla, Staphysagria, Thyroidinum is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Thinnr PROTOCOL. Available dosage form: liquid.

Drug details

Generic Name
Adeps suillus, Adrenalinium, Adrenocorticotrophin, Agrimonia eupatoria flos, Ammounium bromatum, Anacardium orientale, Antimonium crudum, Castanea sativa flos, Calcarea carbonica, Coenzyme A, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Pituitarum posterium, RNA, Sabadilla, Staphysagria, Thyroidinum
Brand Names
Thinnr PROTOCOL
Sponsor
SLIMCELL, LLC
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
CASTANEA SATIVA FLOWER, ADEPS SUILLUS, SEMECARPUS ANACARDIUM JUICE, AMMONIUM BROMIDE, AGRIMONIA EUPATORIA FLOWER, CORTICOTROPIN, EPINEPHRINE, POTASSIUM DICHROMATE, COENZYME A, THYROID, UNSPECIFIED, ANTIMONY TRISULFIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, CORTISONE ACETATE, FUCUS VESICULOSUS, BOS TAURUS HYPOTHALAMUS, SUS SCROFA PITUITARY GLAND, POSTERIOR, SACCHAROMYCES CEREVISIAE RNA, DELPHINIUM STAPHISAGRIA SEED, SCHOENOCAULON OFFICINALE SEED

Indications and Usage

Uses*: Uses*: Provides temporary support during a weight management program. Supports healthy metabolism, improved hormone levels, detoxification, lower stress levels, reduces hunger and cravings, and improved elimination when following a healthy weight management program.

Warnings

Warnings Warnings: If symptoms worsen or persist for more than 7 days, discontinue use and consult your practitioner.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.